Technical Analysis for ZFGN - Zafgen, Inc.

Grade Last Price % Change Price Change
grade F 0.7687 3.82% 0.03
ZFGN closed up 3.82 percent on Thursday, September 19, 2019, on 1.21 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ZFGN trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Wide Bands Range Expansion 3.82%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.88%
Narrow Range Bar Range Contraction 3.88%
Wide Bands Range Expansion 3.88%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.25%
Doji - Bearish? Reversal 6.25%
Outside Day Range Expansion 6.25%

Older signals for ZFGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Zafgen, Inc. is a biopharmaceutical company. The Company is engaged in improving the health and well-being of patients affected by obesity. Beloranib, the Company’s product candidate, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including obesity and hyperphagia, or insatiable life-threatening hunger and hunger-related behaviors, in Prader-Willi Syndrome (PWS), craniopharyngioma-associated obesity, and severe obesity in the general population. PWS is a rare and complex genetic disorder characterized by physiologic, cognitive and behavioral symptoms, including hyperphagia and obesity. Craniopharyngioma is a rare form of benign brain tumor that occurs near the optic nerve, pituitary gland and hypothalamus. Approximately 30% to 50% of cases of craniopharyngioma are diagnosed in childhood and adolescence.
Medicine Biopharmaceutical Organ Systems Obesity Neuroendocrinology Prader Willi Syndrome
Is ZFGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.355
52 Week Low 0.64
Average Volume 532,100
200-Day Moving Average 2.755
50-Day Moving Average 0.8977
20-Day Moving Average 0.7631
10-Day Moving Average 0.7127
Average True Range 0.055
ADX 15.04
+DI 20.1792
-DI 21.3738
Chandelier Exit (Long, 3 ATRs ) 0.761
Chandelier Exit (Short, 3 ATRs ) 0.805
Upper Bollinger Band 0.8895
Lower Bollinger Band 0.6367
Percent B (%b) 0.52
BandWidth 33.12803
MACD Line -0.0533
MACD Signal Line -0.0671
MACD Histogram 0.0139
Fundamentals Value
Market Cap 21.13 Million
Num Shares 27.5 Million
EPS -1.88
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 0.00
Price-to-Book 0.95
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.83
Resistance 3 (R3) 0.82 0.80 0.82
Resistance 2 (R2) 0.80 0.78 0.80 0.81
Resistance 1 (R1) 0.78 0.77 0.79 0.79 0.81
Pivot Point 0.76 0.76 0.76 0.76 0.76
Support 1 (S1) 0.74 0.74 0.75 0.75 0.73
Support 2 (S2) 0.72 0.74 0.72 0.72
Support 3 (S3) 0.70 0.72 0.72
Support 4 (S4) 0.71